Schrodinger Inc (SDGR) Stock Price, Quote & News

Company Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focu...

Industry: Health Information Services

Sector: Healthcare

Phone: 212 295 5800

Website: www.schrodinger.com

Address:

1540 Broadway, 24th Floor, New York, United States

BloomBoom Sep. 2 at 11:32 AM

$SDGR Meine Eier sind schmutzig, bitte leck sie sauber, du Schuft

0 · Reply

bambus3001 Sep. 2 at 11:27 AM

$SDGR 22€ ist und war mein 1.Ziel ,aber Ich hebe es auf 26 -28 an vorläufig . Jemand kauft grosse Pakete Übernahme droht hoffentlich nicht .

0 · Reply

larryr15 Sep. 1 at 9:24 PM

$SDGR probably not a smart idea to fight Bill Gates. Eli Lilly and Bristol Myers.

0 · Reply

madnessofcrowds Sep. 1 at 7:39 PM

$SDGR why are so many trying to short this? it’s just getting started. go long and forget about it for a few years.

0 · Reply

BB_88_ Sep. 1 at 7:31 PM

$SDGR it’s holding well but took a short here stop 21

0 · Reply

BB_88_ Sep. 1 at 6:47 PM

$SDGR crack in 10

0 · Reply

BB_88_ Sep. 1 at 6:36 PM

$SDGR in my option the fade happens soon

0 · Reply

bambus3001 Sep. 1 at 6:25 PM

$SDGR Buy Out Welche Mk wäre bei der wachsenden Firma realitisch 6 bis 8 Mrd Euro sind keine Utopischen Preise . Die ganze Ki Datenbank wäre eigentlich das 5 fache des momentanen Kurses nicht ausgeschlossen . Big Pharma lauern alle an der Seitenlinie ,und eine 20 Mrd Übernahme stemmen die grossen ohne Probleme. Bleibe ein wenig noch abwartend ,wegen Rücksetzer ,um Nachzukaufen.

0 · Reply

StockHunter75 Sep. 1 at 6:19 PM

$SDGR 25 plus coming by Friday.

0 · Reply

BB_88_ Sep. 1 at 6:16 PM

$SDGR try again short here in to close

0 · Reply

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

2026-08-16T13:52:46.000Z - 17 days ago

Schrodinger assumed with a Neutral at UBS

2026-08-16T13:19:59.000Z - 17 days ago

Schrodinger reports inducement grants under Nasdaq listing rule

Aug 14, 2026, 8:30 AM EDT - 19 days ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

2026-08-05T20:50:58.000Z - 27 days ago

Schrodinger raises FY26 drug discovery revenue view $65M-$75M from $55M-$65M

Aug 5, 2026, 4:30 PM EDT - 27 days ago

Schrödinger Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 27 days ago

Schrödinger Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 27 days ago

Schrödinger Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 27 days ago

Schrödinger Slides: Q2 2026

Aug 5, 2026, 4:05 PM EDT - 27 days ago

Schrödinger Reports Second Quarter 2026 Financial Results

2026-08-05T14:13:22.000Z - 27 days ago

Schrodinger announces collaboration, software agreement with Bristol Myers

BMY

Aug 5, 2026, 8:30 AM EDT - 4 weeks ago

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

BMY

2026-07-27T11:35:48.000Z - 5 weeks ago

Schrodinger introduces Bunsen AI co-scientist for molecular discovery

GOOG GOOGL NVDA

Jul 27, 2026, 7:30 AM EDT - 5 weeks ago

Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery

Jul 22, 2026, 8:30 AM EDT - 6 weeks ago

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5

2026-07-20T12:40:40.000Z - 6 weeks ago

Schrodinger reports inducement grants under Nasdaq listing rule

Jun 22, 2026, 12:00 PM EDT - 2 months ago

Schrödinger Transcript: AGM 2026

2026-06-18T12:54:39.000Z - 2 months ago

Schrodinger reports inducement grants under Nasdaq listing rule

May 19, 2026, 2:05 PM EDT - 3 months ago

Schrödinger Transcript: RBC Capital Markets Global Healthcare Conference 2026

2026-05-14T16:24:26.000Z - 3 months ago

Schrodinger price target lowered to $17 from $19 at Morgan Stanley

May 13, 2026, 5:20 PM EDT - 3 months ago

Schrödinger Transcript: Bank of America Global Healthcare Conference 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

Schrödinger Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

Schrödinger Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

Schrödinger Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

Schrödinger Slides: Q1 2026

May 5, 2026, 4:05 PM EDT - 4 months ago

Schrödinger Reports First Quarter 2026 Financial Results

May 4, 2026, 8:30 AM EDT - 4 months ago

Schrödinger to Participate in Upcoming Investor Conferences

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Schrödinger Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Schrödinger Proxy statement: Proxy filing

Apr 21, 2026, 8:30 AM EDT - 4 months ago

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

2026-04-17T12:52:03.000Z - 4 months ago

Schrodinger reports inducement grants under Nasdaq listing rule

2026-04-13T10:44:45.000Z - 5 months ago

Schrodinger price target lowered to $20 from $25 at KeyBanc

Mar 17, 2026, 9:00 AM EDT - 6 months ago

Schrödinger Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

2026-03-17T12:40:30.000Z - 6 months ago

Schrodinger price target lowered to $13 from $18 at UBS

Mar 10, 2026, 1:40 PM EDT - 6 months ago

Schrödinger Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 9:50 AM EST - 6 months ago

Schrödinger Transcript: TD Cowen 46th Annual Health Care Conference

2026-02-26T14:49:36.000Z - 6 months ago

Schrodinger price target lowered to $20 from $24 at BofA

2026-02-25T21:49:18.000Z - 6 months ago

Schrodinger reports FY25 EPS ($1.41) vs. ($2.57) last year

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Slides: Q4 2025

Feb 25, 2026, 4:05 PM EST - 6 months ago

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 11, 2026, 8:30 AM EST - 7 months ago

Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25

Jan 12, 2026, 8:30 AM EST - 8 months ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

Jan 9, 2026, 7:04 AM EST - 8 months ago

Schrodinger to offer Eli Lilly's AI drug discovery platform on its software

LLY

Jan 9, 2026, 7:00 AM EST - 8 months ago

Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

Nov 19, 2025, 11:00 AM EST - 10 months ago

Schrödinger Transcript: Jefferies London Healthcare Conference 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Schrödinger to Present at Jefferies London Healthcare Conference

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Slides: Q3 2025

Nov 5, 2025, 4:05 PM EST - 10 months ago

Schrödinger Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 7:30 AM EDT - 10 months ago

Copernic Catalysts Announces Achievement of Ammonia Catalyst Milestone in Research Collaboration with Schrödinger

Oct 22, 2025, 8:30 AM EDT - 11 months ago

Schrödinger to Announce Third Quarter 2025 Financial Results on November 5

Sep 8, 2025, 11:30 AM EDT - 1 year ago

Schrödinger Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Schrödinger Announces Discontinuation of SGR-2921 Program

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q2 2025

Aug 6, 2025, 4:05 PM EDT - 1 year ago

Schrödinger Reports Second Quarter 2025 Financial Results

Jul 25, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

Jul 18, 2025, 10:25 AM EDT - 1 year ago

Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration

Jul 17, 2025, 8:00 AM EDT - 1 year ago

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target

$Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia$

Jun 27, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

Jun 18, 2025, 12:00 PM EDT - 1 year ago

Schrödinger Transcript: AGM 2025

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Transcript: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Press release: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Slides: Status Update

Jun 12, 2025, 7:00 AM EDT - 1 year ago

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

Jun 4, 2025, 1:25 PM EDT - 1 year ago

Schrödinger Transcript: Jefferies Global Healthcare Conference 2025

May 29, 2025, 5:00 PM EDT - 1 year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

May 29, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

May 28, 2025, 12:22 PM EDT - 1 year ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD IBB ILMN NVS

May 22, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Present at Jefferies Global Healthcare Conference

May 20, 2025, 6:30 AM EDT - 1 year ago

Schrödinger Announces CFO Appointment

May 14, 2025, 4:40 PM EDT - 1 year ago

Schrödinger Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 9:30 AM EDT - 1 year ago

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q1 2025

May 7, 2025, 4:05 PM EDT - 1 year ago

Schrödinger Reports Strong First Quarter 2025 Financial Results

BloomBoom Sep. 2 at 11:32 AM

$SDGR Meine Eier sind schmutzig, bitte leck sie sauber, du Schuft

0 · Reply

bambus3001 Sep. 2 at 11:27 AM

$SDGR 22€ ist und war mein 1.Ziel ,aber Ich hebe es auf 26 -28 an vorläufig . Jemand kauft grosse Pakete Übernahme droht hoffentlich nicht .

0 · Reply

larryr15 Sep. 1 at 9:24 PM

$SDGR probably not a smart idea to fight Bill Gates. Eli Lilly and Bristol Myers.

0 · Reply

madnessofcrowds Sep. 1 at 7:39 PM

$SDGR why are so many trying to short this? it’s just getting started. go long and forget about it for a few years.

0 · Reply

BB_88_ Sep. 1 at 7:31 PM

$SDGR it’s holding well but took a short here stop 21

0 · Reply

BB_88_ Sep. 1 at 6:47 PM

$SDGR crack in 10

0 · Reply

BB_88_ Sep. 1 at 6:36 PM

$SDGR in my option the fade happens soon

0 · Reply

bambus3001 Sep. 1 at 6:25 PM

0 · Reply

StockHunter75 Sep. 1 at 6:19 PM

$SDGR 25 plus coming by Friday.

0 · Reply

BB_88_ Sep. 1 at 6:16 PM

$SDGR try again short here in to close

0 · Reply

Stocktwits Sep. 1 at 6:07 PM

$SDGR added to watchlist

0 · Reply

Trader_Ty Sep. 1 at 6:05 PM

$SDGR strong

0 · Reply

BB_88_ Sep. 1 at 4:14 PM

$SDGR short 20.45

1 · Reply

Yingtrader7 Sep. 1 at 4:05 PM

$NSYS top movers $SDGR , $APP , $WING , $MOBI for me.

0 · Reply

BB_88_ Sep. 1 at 3:28 PM

$SDGR first shirt didn’t work out trying again 20.4

0 · Reply

BB_88_ Sep. 1 at 2:36 PM

$SDGR short here day trade only

0 · Reply

bambus3001 Sep. 1 at 2:08 PM

$SDGR Private Neulinge sind momentan nicht zu erkennen ohne Big News oder Q 3 im Herbst,neu einzusteigen. Big Player tauschen Pakete , Und Ich vermute ein Buy out im Winter ,wenn noch 1tolles Quartal kommt . Und der Trend ist jetzt eingeschlagen Richtung Nordpol.

0 · Reply

BloomBoom Sep. 1 at 1:29 AM

$SDGR

0 · Reply

bambus3001 Aug. 31 at 6:01 AM

$SDGR Hallo an alle treuen SDGR Freunde. DieseWoche wird zeigen ,das viel Potenzial diese Firma besitzt. Politisch hoffe Ich ,das keine gravierenden Turbulenzen vieles erschweren auf den Weg zu neuen Höhen. Bleibe sehr positiv gestimmt !!!

1 · Reply

bambus3001 Aug. 28 at 7:24 PM

$SDGR Angsthasen an roten Tagen raus ,wie heute , Geduldige und professionelle Investoren sammeln weitere Stücke gerne günstiger ein 😉😀

0 · Reply

bambus3001 Aug. 28 at 1:54 PM

$SDGR 22 Mein 1.Ziel fast erreicht .

0 · Reply

bambus3001 Aug. 27 at 10:47 PM

$SDGR Schön regelmäßig zum Börsenende werden Pakete getauscht , da kauft sich jemand wohl grösser ein . Wer ? Wir werden es erfahren

0 · Reply

Market Cap	1.44B
Revenue (ttm)	255.87M
Net Income (ttm)	-103.27M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-40.36%
Debt to Equity Ratio	0.00

Volume	1,507,800
Avg Vol	1,192,742
Day's Range	N/A - N/A
Shares Out	73.83M
Stochastic %K	93%
Beta	1.63
Analysts	Strong Sell
Price Target	$21.43